Information Provided By:
Fly News Breaks for September 9, 2019
ZBH
Sep 9, 2019 | 08:12 EDT
Wells Fargo analyst Lawrence Biegelsen raised his price target for Zimmer Biomet to $158 from $150 after meeting with management. The analyst notes that the company pulled forward its growth expectations by 6 months given the progress in manufacturing, new product introductions and personnel, and that it believes supply is not a constraint for ROSA given the controlled roll-out and there is significant demand. Biegelsen reiterates an Outperform rating on the shares.
News For ZBH From the Last 2 Days
There are no results for your query ZBH